HOME >> BIOLOGY >> NEWS
Columbia University launches multi-year campaign to support stem cell research

NEW YORK, NY, June 15, 2005 Columbia University Medical Center (CUMC) announced today that it is halfway toward realizing the first phase of a multi-year campaign to build upon the university's groundbreaking stem cell research and lead the effort to fully realize the therapeutic potential of stem cells. Of the $50 million goal for the first stage of the campaign, $25 million has been raised from the private sector, specifically for diabetes and neural stem cell research.

Columbia University Medical Center researchers are at the forefront of an extraordinary movement to revolutionize medical approaches to therapeutics through its Stem Cell Initiative. Columbia's leadership in developmental biology, neuroscience research, transplantation, and cell replacement therapy uniquely positions the university to push stem cell research forward, and more than 40 CUMC researchers are currently conducting leading stem cell studies.

"This initiative will provide our researchers with the resources necessary to fully realize the potential of stem cells," said Gerald D. Fischbach, M.D., executive vice president of Columbia University Medical Center and dean of the faculty of medicine at Columbia's College of Physicians and Surgeons. "Columbia continues to be a leader in this revolutionary health technology that holds the promise to benefit people suffering from a wide variety of debilitating health problems."

Federal restrictions on human embryonic stem cell research funding and lagging state funds have limited available government support for this emerging and promising research, prompting CUMC to reach out to the private sector with this crucial stem cell initiative.

CUMC researchers are currently exploring the vast potential of stem cells to treat a wide range of illnesses, including Parkinson's disease, amyotrophic lateral sclerosis (ALS), diabetes, pancreatic cancer, leukemia, stroke and other diseases of the nervous system, liver, eye,
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
15-Jun-2005


Page: 1 2 3

Related biology news :

1. Columbia University Medical Center awarded $3 million to drive Alzheimers genetics research
2. Columbia scientists determine 3-dimensional structure of cells fuel gauge
3. Columbia University licenses next-generation DNA sequencing technology
4. New bird discovered on unexplored Columbian mountain
5. Columbia University Medical Center receives major new NIH Clinical Science investment funds
6. Columbia University awards 2006 Horwitz Prize to biologist who explained gene transcription
7. Columbia University receives $16.9 million NIEHS award to study arsenic in ground water
8. Contaminants linked to sturgeon decline in Columbia river
9. Columbia University Medical Center researchers discover potential mechanism for tumor growth
10. UF, Columbia scientists closer to new cancer detection method
11. Columbia University awards 2005 Horwitz Prize to Israeli structural biologist

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/24/2017)... March 24, 2017 The Controller General of Immigration ... Abdulla Algeen have received the prestigious international IAIR Award for ... Continue Reading ... ... Deputy Controller Abdulla Algeen (small picture on the right) have received the ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
(Date:3/22/2017)... March 21, 2017 Vigilant Solutions , ... law enforcement agencies, announced today the appointment of retired ... of public safety business development. Mr. Sheridan ... experience, including a focus on the aviation transportation sector, ... recent position, Mr. Sheridan served as the Aviation Liaison ...
Breaking Biology News(10 mins):
(Date:4/27/2017)... and RESEARCH TRIANGLE PARK, N.C. ... Corporation (NASDAQ: UTHR ) today announced that ... to $250 million of the company,s common stock. This ... through December 31, 2017. Purchases may be made in ... negotiated transactions from time to time as determined by ...
(Date:4/27/2017)... ... April 27, 2017 , ... This month ... (eConsent) solution that simplifies research studies, accelerates study startup, and improves participant engagement. ... Consent™ is the first and only IRB-integrated eConsent solution . , “Our ...
(Date:4/27/2017)... (PRWEB) , ... April 27, ... ... today announced a comprehensive rebrand and a name change to Fluence Analytics. ... industrial and laboratory monitoring of polymer and biopharmaceutical manufacturing processes and R&D ...
(Date:4/27/2017)... April 27, 2017  Kinexum, a distinguished resource for ... announces the appointment of Thomas C. Seoh ... Fleming, M.D., Kinexum founder, who becomes Executive Chairman and ... Kinexum clients. Thomas Seoh commented, ... Kinexum mission and lead the firm,s remarkable team of ...
Breaking Biology Technology:
Cached News: